Rapid evidence profile #58: Examining the use of serosurveillance approaches to monitor diseases and conditions and inform policy decisions

dc.contributor.author	Bain, T
dc.contributor.author	Bhuiya, AR
dc.contributor.author	Dass, R
dc.contributor.author	Alam, S
dc.contributor.author	Phelps, A
dc.contributor.author	Wilson, MG
dc.date.accessioned	2025-05-29T15:15:44Z
dc.date.available	2025-05-29T15:15:44Z
dc.date.issued	2023-12
dc.description.abstract	An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories, about the use of serosurveillance approaches to monitor diseases and conditions and inform policy decisions in response to a decision-maker’s request.	en_US
dc.description.sponsorship	This rapid evidence profile was funded by the Public Health Agency of Canada.	en_US
dc.identifier.citation	Bain T, Bhuiya A, Dass R, Alam S, Phelps A, Wilson MG. Rapid evidence profile #58: Examining the use of serosurveillance approaches to monitor diseases and conditions and inform policy decisions, Hamilton: McMaster Health Forum, 6 December 2023.	en_US
dc.identifier.uri	http://hdl.handle.net/11375/31739
dc.language.iso	en	en_US
dc.relation.ispartofseries	REP 58;
dc.subject	serosurveillance	en_US
dc.subject	diseases	en_US
dc.subject	conditions	en_US
dc.subject	policy	en_US
dc.title	Rapid evidence profile #58: Examining the use of serosurveillance approaches to monitor diseases and conditions and inform policy decisions	en_US

Files

Now showing 1 - 2 of 2

Now showing 1 - 1 of 1